Insiders Updates
A Guide To The Risks Of Investing In Altimmune Inc (ALT)
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Menu
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Altimmune Inc revealed its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recent filing unveils that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Altimmune Inc
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recent filing unveils that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17